Agenus (AGEN) Consolidated Net Income (2010 - 2026)

Agenus' (AGEN) quarterly Consolidated Net Income came in at $364000.0 in Q1 2026, up 101.38% year-on-year from $180748.9 in Q1 2025, and up 122.05% quarter-over-quarter from -$1.7 million in Q4 2025.

Agenus (AGEN) Consolidated Net Income (2010 - 2026) Analysis & Trends

Agenus' Consolidated Net Income history runs 17 years deep, the most recent figure standing at $364000.0 for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 101.38% year-over-year to $364000.0 in Q1 2026; TTM through Mar 2026 was -$38.3 million, a 81.22% increase from a year earlier, with the FY2025 full-year figure at -$415.1 million, up 20.05% from the prior year.
  • Consolidated Net Income rose to $364000.0 in Q1 2026 per AGEN's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $364000.0 in Q1 2026 and bottomed at -$68.3 million in Q3 2024.
  • The 5-year median for Consolidated Net Income is -$45.2 million (2022), against an average of -$38.2 million.
  • Across the five-year window, Consolidated Net Income plunged 871.9% in 2024 and soared 101.38% in 2026, its largest moves.
  • Year by year, Consolidated Net Income stood at -$58.1 million in 2022, then jumped by 91.67% to -$4.8 million in 2023, then plunged by 871.9% to -$47.0 million in 2024, then surged by 96.49% to -$1.7 million in 2025, then soared by 122.05% to $364000.0 in 2026.
  • Per Business Quant, the three latest AGEN Consolidated Net Income figures stand at $364000.0 (Q1 2026), -$1.7 million (Q4 2025), and -$7.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn - -37.09 Mn
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -14.46 Mn
4 BeOne Medicines 471.12 Bn 466.33 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.84 Bn 114.59 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.89 Bn 61.14 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.74 Bn 62.74 Bn - -26.94 Mn
8 Argenx Se 55.83 Bn 50.64 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.34 Bn 34.34 Bn 959.66 Mn 205.99 Mn
10 Agenus 231.82 Mn 196.82 Mn 33.74 Mn 364,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 364,000.00
Dec 31, 2025 -1.65 Mn
Sep 30, 2025 -6.97 Mn
Jun 30, 2025 -30.05 Mn
Mar 31, 2025 -26.29 Mn
Dec 31, 2024 -47.01 Mn
Sep 30, 2024 -68.25 Mn
Jun 30, 2024 -62.48 Mn
Mar 31, 2024 -63.16 Mn
Dec 31, 2023 -4.84 Mn
Sep 30, 2023 -46.74 Mn
Jun 30, 2023 -55.07 Mn
Mar 31, 2023 -55.17 Mn
Dec 31, 2022 -58.05 Mn
Sep 30, 2022 -42.25 Mn
Jun 30, 2022 -45.17 Mn
Mar 31, 2022 -36.66 Mn
Dec 31, 2021 -55.27 Mn
Sep 30, 2021 133.22 Mn
Jun 30, 2021 -130.07 Mn